Showing 7611-7620 of 8649 results for "".
- GSK, CureVac Partner to Develop mRNA Vaccines for COVID-19 Variantshttps://modernod.com/news/gsk-curevac-partner-to-develop-mrna-vaccines-for-covid-19-variants/2478831/GlaxoSmithKline entered into a new collaboration with CureVac to develop a multi-valent mRNA candidate vaccine to address multiple emerging variants of COVID-19, the companies announced Wednesday. “We believe that next-generation vaccines will be crucial in the continued fight against COVID
- Breakthrough by Moran Eye Center Scientist, Colleagues Fuels New Line of Disease Researchhttps://modernod.com/news/breakthrough-by-moran-eye-center-scientist-colleagues-fuels-new-line-of-disease-research/2478830/Scientists like the John A. Moran Eye Center’s Paul S. Bernstein, MD, PhD, know a special class of lipids, or fatty acids, found in the retina of the eye and in just a few other parts of the body play an important role in maintaining vision. But it’s been difficult to study whether giving
- J&J’s Single-Dose COVID-19 Vaccine 66% Effectivehttps://modernod.com/news/jjs-single-dose-covid-19-vaccine-66-effective/2478814/Johnson & Johnson reported topline results Friday showing that its investigational single-dose vaccine candidate Ad26.COV2.S met all primary and key secondary endpoints of the phase 3 ENSEMBLE study, with an overall efficacy rate of 66% at preventing moderate-to-severe COVID-19, 28 days after
- Johnson & Johnson Vision Names Peter Menziuso New Worldwide President for Vision Carehttps://modernod.com/news/johnson-johnson-vision-announces-peter-menziuso-as-the-new-worldwide-president-for-vision-care/2478812/Johnson & Johnson Vision announced that Peter Menziuso will assume the role of Worldwide President, Vision Care, for Johnson & Johnson Vision immediately. Mr. Menziuso replaces Swami Raote, who retired at the end of 2020, after a 29-year tenure with Johnson & Johnson. Mr. Menzi
- Influence of Patient Mask Wearing on Ocular Injection-Related Infection Unclearhttps://modernod.com/news/influence-of-patient-mask-wearing-on-ocular-injection-related-infection-unclear/2478807/Pre-pandemic research suggests that mask wearing by clinicians may reduce infectious endophthalmitis in patients receiving ocular injections, and that a no-talking policy can also help. But the influence of mask wearing by patients themselves still remains to be precisely defined, ressearchers sa
- US to Bolster COVID-19 Vaccine Supply With Millions More Doses this Summerhttps://modernod.com/news/us-to-bolster-covid-19-vaccine-supply-with-millions-more-doses-this-summer/2478803/The Biden administration on Tuesday said it would boost the supply of coronavirus vaccines sent to states, tribes and territories by about 16% to a minimum of 10 million doses a week, for the next 3 weeks. According to the administration, this increase of 1.4 million doses per week will allow 
- Google Commits $150M to COVID-19 Vaccine Education, Partnering With One Medical to Open Vaccination Siteshttps://modernod.com/news/google-commits-150m-to-covid-19-vaccine-education-partnering-with-one-medical-to-open-vaccination-sites/2478801/Google is committing $150 million to promote COVID-19 vaccine education and equitable distribution to underserved communities, the tech giant announced Monday, as
- Bariatric Surgery May Curb Diabetic Eye Disease Incidence but Worsen Existing Retinopathyhttps://modernod.com/news/bariatric-surgery-may-curb-diabetic-eye-disease-incidence-but-worsen-existing-retinopathy/2478796/Bariatric surgery was associated with fewer cases of diabetic retinopathy (DR), but early worsening was more severe in patients who already had the condition, a systematic review and meta-analysis reveals, according to a Reuters report. </
- Center For Sight is the First Practice Worldwide to Offer the OptiBlue IOLhttps://modernod.com/news/center-for-sight-is-the-first-practice-worldwide-to-offer-the-optiblue-iol/2478793/Center For Sight, which operates 14 eye clinics and surgery centers in Southwest Florida, is the first eye care practice to offer the new OptiBlue IOLs (Johnson & Johnson Vision), an advanced intraocular lens technology that filters violet light to improve contrast and clarity for cataract pa
- FTC to Probe Physician Practice Consolidation and Impact on Market Competitionhttps://modernod.com/news/ftc-to-probe-physician-practice-consolidation-and-impact-on-market-competition/2478787/The federal government plans to study the impact of physician group and healthcare facility consolidation during the past six years, according to a FierceHealthcare